Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2-· production in the intact coronary endothelium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Zhang, Andrew Y ^a   Teggatz, Eric G ^a   Zou, Ai Ping ^a   Campbell, William B ^a   Li, Pin Lan ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Collagen; Coronary artery; Free radicals; Signal transduction; Sphingolipid

Indexed keywords

APOCYNIN; ARGININE; BRADYKININ; CALCIUM; CERAMIDE; CITRULLINE; ENDOSTATIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SPHINGOMYELIN PHOSPHODIESTERASE; SUPEROXIDE; TIRON; ANGIOGENESIS INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY; COW; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CATTLE; CORONARY BLOOD VESSEL; DRUG EFFECT; DRUG INTERACTION; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; BRADYKININ; CALCIUM; CATTLE; CERAMIDES; CORONARY VESSELS; DRUG INTERACTIONS; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; NADP; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SUPEROXIDES;

EID: 12344286763     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00174.2004     Document Type: Article

References (40)

1. Boehm T, Folkman J, Browder T, and O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404-407, 1997.
2. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
3. Deininger MH, fimmen BA, Thai DR, Schluesener HJ, and Meyermann R. Aberrant neuronal and paracellular deposition of endostatin in brains of patients with alzheimer's disease. J Neurosci 22: 10621-10626, 2002.
4. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, and Sukhatme VP. Endostatin induces endothelial cell apoptosis. J Biol Chem 274: 11721-11726, 1999.
5. Dhanabal M, Yolk R, Ramchandran R, Simons M, and Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun 258: 345-352, 1999.
6. Dimmeler S, Dernbach E, and Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477: 258-262, 2000.
7. Dixelius J, Larsson H, Sasaki T, Holmqvist Lu L, Engstrom A, Timpl R, Welsh M, and Claesson-Welsh L. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95: 4303-3411, 2000.
8. Dussmann H, Kogel D, Rehm M, and Prehn JH. Mitochondrial membrane permeabilization and Superoxide production during apoptosis. A single-cell analysis. J Biol Chem 278: 12645-12649, 2003.
9. Fleming I and Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
10. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000.
11. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, and Gulbins E. CD95 signaling via ceramide membrane rafts. J Biol Chem 276: 20589-20596, 2001.
12. Gupta N, Nodzenski E, Khodarev NN, Yu J, Khorasani L, Beckett MA, Kufe DW, and Weichselbaum RR. Angiostatin effects on endothelial cells mediated by ceramide and RhoA. EMBO Rep 2: 536-540, 2001.
13. 2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol Cell Physiol 280: C1140-C1150, 2001.
14. Karihaloo A, Karumanchi SA, Barasch J, Jha V, Nickel CH, Yang J, Grisaru S, Bush KT, Nigam S, Rosenblum ND, Sukhatme VP, and Cantley LG. Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc Natl Acad Sci USA 98: 12509-12514, 2001.
15. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, and Sukhatme VP. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7: 811-822, 2001.
16. Kim GW, Kondo T, Noshita N, and Chan PH. Manganese Superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of Superoxide radicals. Stroke 33: 809-815, 2002.
17. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS, and Kwon YG. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277: 27872-27879, 2002.
18. Koshida R, Ou J, Matsunaga T, Chilian WM, Oldham KT, Ackerman AW, and Pritchard KA Jr. Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation 107: 803-806, 2003.
19. Kurosaka D, Yoshida K, Yasuda J, Yokoyama T, Kingetsu I, Yamaguchi N, Joh K, Matsushima M, Saito S, and Yamada A. Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis. Ann Rheum Dis 62: 677-679, 2003.
20. Kuzkaya N, Weissmann N, Harrison DG, and Dikafov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
21. Lee SJ, Jang JW, Kim YM, Lee HI, Jeon JY, Kwon YG, and Lee ST. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 519: 147-152, 2002.
22. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp BE, and Pearson MB. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 9: 845-848, 1999.
23. Mimeault M. New advances on structural and biological functions of ceramide in apoptotic/necrotic cell death and cancer. FEBS Lett 23: 9-16, 2002.
24. Miosge N, Sasaki T, and Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J 13: 1743-1750, 1999.
25. Mori T and Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated Superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42: 588-593, 2003.
26. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 33: 29-55, 1999.
27. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, and Flynn E. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
28. Pettus BJ, Chalfant CE, and Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585: 114-125, 2002.
29. Ramchandran R, Karumanchi SA, Hanai J, Alper SL, and Sukhatme VP. Cellular actions and signaling by endostatin. Crit Rev Eukaryot Gene Expr 12: 175-191, 2002.
30. Rehn M and Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci USA 91: 4234-4238, 1994.
31. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, and Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 98: 1024-1029, 2001.
32. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, and Timpl R. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J 18: 6240-6248, 1999.
33. Shichiri M and Hirata Y. Antiangiogenesis signals by endostatin. FASEB J 15: 1044-1053, 2001.
34. Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M, and Dimmeler S. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J 16: 706-709, 2002.
35. Venema RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol 2: 1755-1762, 2002.
36. Wickstrom SA, Alitalo K, and Keski-Oja J. Endostatin associates with integrin α5β1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 62: 5580-5589, 2002.
37. 2+ and NO in endothelium of coronary arteries. Am J Physiol Heart Circ Physiol 283: H2725-H2732, 2002.
38. Zhang DX, Yi FX, Zou AP, and Li PL. Role of ceramide in TNF-α-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol 283: H1785-H1794, 2002.
39. Zhang DX, Zou AP, and Li PL. Ceramide reduces endothelium-dependent vasodilation by increasing Superoxide production in small bovine coronary arteries. Circ Res 88: 824-831, 2001.
40. Zhang DX, Zou AP, and Li PL. Ceramide-induced activation of NAD(P)H oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol 284: H605-H612, 2003.